We are happy to announce that our partner’s Pain Alliance Europe project, the Brain, Mind, and Pain Patient-Centred Innovation Grant reached its second edition.

The project was initiated by Pain Alliance Europe and supported by Grünenthal Group with the main aim of encouraging patient-centred innovation having, as a result, the improvement of the living conditions of pain patients.

The European Pain Federation EFIC, the European Academy of Neurology and the European Federation of Neurological Associations sit on the steering board of the grant and are partners of the initiative.

The biennial grant provided by Grünenthal addresses individual applicants as well as different organisations’ initiatives and partnerships, invited to present their innovation projects or ideas with direct impact on brain, mind, and pain patients’ quality of life.

Patients, and the people associated with them, will know that there is a need to raise awareness of the social and psychological impact they will experience regarding the various aspects of living with chronic pain or neurological conditions. This second edition of the Brain, Mind, and Pain Grant will look into ways of reducing the stigma associated with these conditions.

The new edition 2019-2020 will address the BMP Grant theme:

Stop stigma! Reduce stigma to improve quality of life for brain, mind and pain patients 

The Jury composed of patients representatives led by Pain Alliance Europe perform the selection of the Brain, Mind, and Pain Patient-Centred Innovation Grant winning candidate(s).

The BMP Grant documentation will be available by June 2019. Please visit the website regularly to find out more about the eligibility criteria and the details of the call for proposals.The application period has been extended to 6 months to allow each participant to provide all the details of the project and review the input.

Subscribe to the European Pain Federation Newsletter!

Don't worry, we will not spam you, you can unsubscribe at any time.

For more information on the transmission and use of your personal data, please refer to our privacy policy.Pr.

You have Successfully Subscribed!